Pharmaceutical and Biotechnology Services and Supply Chain M&A Activity
Tom Cowap, Managing Director in Baird’s European Healthcare Investment Banking team focusing on Pharma Services and Life Sciences, was recently featured in Molecule to Market – a podcast series focused on the life science outsourcing space.
In the episode, Q123 M&A Roundtable, Tom joins host Raman Sehgal and panelists Ross Burn, Chief Executive at CatSci, and James Hales, Senior Director at NorthEdge, to discuss pharmaceutical and biotechnology supply chain M&A activity, with topics including:
- How the market headwinds, continued consolidation and how macro slowdowns are impacting M&A activity in our space.
- Why PE is still very keen on the pharma and biotech ecosystem and how the size and shape of deals and investments in the market have changed.
- How an investment is enabling Ross’ business to accelerate growth in several directions.
- A look forward to geographic shifts, continued biotech outsourcing, and how there maybe riches in the niches of sub-segments of the pharma services ecosystem.
Listen to the Podcast:
Interested in learning more? Connect with Baird Global Investment Banking.
Learn more about Baird's Global Pharmaceutical Services expertise.